• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.

Co-authoring Researcher

Co-inventing Researcher

Researcher similar to the Researcher

Article similar to the Researcher

Patent similar to the Researcher

Research Project similar to the Researcher

Article(J-GLOBAL estimation)

Patent(J-GLOBAL estimation)

Rchr
J-GLOBAL ID:201801002370422029   Update date: Feb. 27, 2025

SUEMIZU HIROSHI

SUEMIZU HIROSHI
Clips
Research field  (1): Laboratory animal science
Research theme for competitive and other funds  (15):
  • 2019 - 2023 Development of a composite humanized liver chimeric mouse that contributes to pharmacokinetic studies and its application to drug discovery research
  • 2017 - 2019 The functional characterization of cytochrome P450 enzymes from preclinical species
  • 2016 - 2019 Monitoring of transplanted hepatocytes and analysis of immune rejection responses in the hepatocyte chimeric mouse system.
  • 2016 - 2019 Development of human specific hepatotoxicity evaluation method using humanized liver mouse and elucidation of species differences in the pathogenesis of toxicity
  • 2013 - 2015 Basic research for development of artificial liver stem cell
Show all
Papers (199):
  • Shugo Suzuki, Min Gi, Takuma Kobayashi, Noriyuki Miyoshi, Nao Yoneda, Shotaro Uehara, Yuka Yokota, Ikue Noura, Masaki Fujioka, Arpamas Vachiraarunwong, et al. Urinary bladder carcinogenic potential of 4,4'-methylenebis(2-chloroaniline) in humanized-liver mice. Toxicological sciences : an official journal of the Society of Toxicology. 2024. 202. 2. 210-219
  • Yoshiyuki Sakai, Tatsuki Fukami, Shinsaku Tokumitsu, Masataka Nakano, Shimon Nakashima, Yuichiro Higuchi, Shotaro Uehara, Nao Yoneda, Hiroshi Suemizu, Miki Nakajima. Impact of miR-222-3p-mediated downregulation of arylacetamide deacetylase on drug hydrolysis and lipid accumulation. Drug Metabolism and Pharmacokinetics. 2024. 101007-101007
  • Makiko Shimizu, Shotaro Uehara, Katsuhiro Ohyama, Haruka Nishimura, Yoichi Tanaka, Yoshiro Saito, Hiroshi Suemizu, Sayaka Yoshida, Hiroshi Yamazaki. Pharmacokinetic Models Scaled-up from Humanized-liver Mouse Data Can Account for Drug Monitoring Results of Atomoxetine and Its 4-Hydroxylated andN-Demethylated Metabolitesin Pediatric Patients Genotyped for CytochromeP450 2D6. Drug Metabolism and Disposition. 2023. DMD-AR
  • Shotaro Uehara, Masahiko Yasuda, Yuichiro Higuchi, Nao Yoneda, Kenji Kawai, Masami Suzuki, Hiroshi Yamazaki, Hiroshi Suemizu. SGX523 causes renal toxicity through aldehyde oxidase-mediated less-soluble metabolite formation in chimeric mice with humanized livers. Toxicology letters. 2023. 388. 48-55
  • 上原 正太郎, 保田 昌彦, 樋口 裕一郎, 米田 直央, 川井 健司, 山崎 浩史, 末水 洋志. SGX523はヒト肝キメラマウスにおいてアルデヒド酸化酵素による難溶性代謝物形成を介して腎毒性を引き起こす. The Journal of Toxicological Sciences. 2023. 48. Suppl. S205-S205
more...
MISC (55):
  • Kazuhiro Murai, Hayato Hikita, Tasuku Nakabori, Shinji Kuriki, Emi Sometani, Jihyun Sung, Akiyoshi Shimoda, Makoto Fukuoka, Satoshi Shigeno, Akira Nishio, et al. SUPPRESSION OF HSPG2 EXPRESSION INHIBITS HBV ENTRY AND REPLICATION VIA INCREASED cMET EXPRESSION. HEPATOLOGY. 2023. 78. S613-S613
  • Akiyoshi Shimoda, Hayato Hikita, Kazuhiro Murai, Shinji Kuriki, Emi Sometani, Jihyun Sung, Makoto Fukuoka, Satoshi Shigeno, Akira Nishio, Takahiro Kodama, et al. FDA APPROVED DRUG LIBRARY SCREENING TO IDENTIFY COMPOUNDS THAT REDUCE HBS ANTIGEN. HEPATOLOGY. 2023. 78. S521-S521
  • 遠藤墾, 遠藤墾, 大山夏実, 渡邊恭子, 早川佳那, 早川佳那, 頼添賦, 中野有紀, 藤岡慶史, 末水洋志, et al. マウス顆粒膜細胞の除去による卵巣機能不全モデルマウスの作出. 日本実験動物学会総会講演要旨集(Web). 2023. 70th
  • 早川佳那, 早川佳那, 中野有紀, 遠藤墾, 遠藤墾, 平手良和, 平手良和, 末水洋志, 後藤元人, 高橋利一, et al. TRECK法を用いた子宮内膜上皮置換. 日本実験動物学会総会講演要旨集(Web). 2023. 70th
  • 村井一裕, 疋田隼人, 中堀輔, 栗木真治, 染谷愛美, 成志弦, 下田彬允, 福岡誠, 滋野聡, 西尾啓, et al. HSPG2発現抑制はcMET発現上昇を介してHBVの侵入ならびに複製を阻害する. 肝細胞研究会プログラム・抄録集. 2023. 30th
more...
Patents (5):
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page